Takikawa, Hajime
9 papers on CoChatORCID 0000-0002-6231-6786
Most cited papers
- Verified
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
Nakamura, M., Nishida, N., Kawashima, M., Aiba, Y., Tanaka, A., Yasunami, M., Nakamura, H., Komori, A., Nakamuta, M., Zeniya, M., et al. (2012) · The American Journal of Human Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 267
- Verified
Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid
Honda, A., Ikegami, T., Nakamuta, M., Miyazaki, T., Iwamoto, J., Hirayama, T., Saito, Y., Takikawa, H., Imawari, M., & Matsuzaki, Y. (2013) · Hepatology
Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms
Cited by 210
- Verified
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
Cordell, H. J., Fryett, J. J., Ueno, K., Darlay, R., Aiba, Y., Hitomi, Y., Kawashima, M., Nishida, N., Khor, S.-S., Gervais, O., et al. (2021) · Journal of Hepatology
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 182
- Verified
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
Devarbhavi, H., Aithal, G., Treeprasertsuk, S., Takikawa, H., Mao, Y., Shasthry, S. M., Hamid, S., Tan, S. S., Philips, C. A., George, J., et al. (2021) · Hepatology International
Drug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology
Cited by 181
- Verified
Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis
Tanaka, A., Hirohara, J., Nakano, T., Matsumoto, K., Chazouillères, O., Takikawa, H., Hansen, B. E., Carrat, F., & Corpechot, C. (2021) · Journal of Hepatology
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 148
- Verified
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis
Asselta, R., Paraboschi, E. M., Gerussi, A., Cordell, H. J., Mells, G. F., Sandford, R. N., Jones, D. E., Nakamura, M., Ueno, K., Hitomi, Y., et al. (2021) · Gastroenterology
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 55
- Verified
Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population
Kawashima, M., Hitomi, Y., Aiba, Y., Nishida, N., Kojima, K., Kawai, Y., Nakamura, H., Tanaka, A., Zeniya, M., Hashimoto, E., et al. (2017) · Human Molecular Genetics
Liver Diseases and ImmunityGenetic Associations and Epidemiology
Cited by 52
- Verified
Autoantibody status and histological variables influence biochemical response to treatment and long‐term outcomes in Japanese patients with primary biliary cirrhosis
Nakamura, M., Kondo, H., Tanaka, A., Komori, A., Ito, M., Yamamoto, K., Ohira, H., Zeniya, M., Hashimoto, E., Honda, M., et al. (2015) · Hepatology Research
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 49
- Verified
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis
Yagi, M., Matsumoto, K., Komori, A., Abe, M., Hashimoto, N., Inao, M., Namisaki, T., Kawata, K., Ninomiya, M., Fujii, H., et al. (2020) · Liver International
Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free